Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05774236Phase 3Completed
Phase 3, randomised trial in fetal growth restriction (FGR) (2 arms), sponsored by Hospital Universitario 12 de Octubre. Primary endpoint: Rate of vaginal delivery at 2 days. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05774236.